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With more than 7.8 million confirmed cases and over 430,000 
deaths COVID-19 has had an impact on the whole world (16.06.2020). 
In many countries the peak of the first wave seems to be passing and 
strict lockdown measures are being eased gradually. It is important 
to implement risk mitigation procedures to ensure the safety of those 
people returning to the workplace and participating in “public life”. 
Despite mounting evidence that faeces are infectious there seems to be 
little discussion of this, no public awareness of risk, or implementation 
of potential mitigation strategies. In addition, lasting alterations in 
the gut microbiome of patients infected with SARS-CoV-2 have been 
observed in at least two pilot studies. Dysbiosis in the gut microbiome 
influences different biochemical functions and is associated with 
diverse diseases, effecting the immune system, metabolic states and 
mental health. In consequence, there could be unidentified long-term 
health risks of SARS-CoV-2 infections in the gut. 
In a meta-analysis of 60 studies, comprising 4243 COVID-19 
patients Cheung et al. showed that the pooled prevalence of any 
gastrointestinal symptoms was 17.6% (95% CI: 12.3-24.5%), with 
11.8% occurring with non-severe COVID 19 symptoms and 17.1% 
with severe symptoms [1]. Not all studies reported all individual 
gastrointestinal symptoms, consequently the pooled prevalence of 
anorexia was 26.8% (95% CI: 16.2-40.8), diarrhoea 12.5% (95% CI: 
9.6-16.0), nausea/vomiting 10.2% (95% CI: 6.6-15.3), and abdominal 
pain/discomfort 9.2% (95% CI: 5.7-14.5).
Using immunofluorescent staining, Xiao et al. showed expression of 
the ACE2 protein in the glandular cells of gastric, duodenal, and rectal 
epithelia [2]. They also demonstrated staining of viral nucleocapsid 
protein in the same epithelia cell populations. In addition, the authors 
showed that of 73 hospitalized patients in the study, 53% tested positive 
for SARS-CoV-2 RNA in stool. Wu et al. confirmed these findings and 
went a step further and followed the patients over time showing that 
respiratory samples remained positive for SARS-CoV-2 RNA for a mean 
of 16.7 days (SD 6.7) and faecal samples remained positive for a mean 
of 27.9 days (SD 10.7) after first symptom onset [3]. These findings have 
been repeated and verified in a number of additional studies, in adults 
and children, asymptomatic, mild and severe COVID-19 patients. In 
addition, Wu et al. showed that from 60 patients that were released from 
hospital after clinical recovery 10% were still positive for SARS-CoV-2 
RNA in anal swab [4]. At least four independent studies have been 
published reporting the isolation of infectious SARS-CoV-2 from stool 
samples. For example, Wang et al. reported the isolation of live SARS-
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CoV-2 from stool samples (non-diarrhoea) from two patients [5]. This 
is of particular interest since various studies have shown the production 
of bioaerosols during toilet flushing [6]. That is significant since new 
data shows that airborne transmission plays a major role for the spread 
of SARS-CoV-2 [7]. Indeed, in a report Liu et al. studied the potential 
aerosol transmission of SARS-CoV-2 in two Wuhan hospitals [8]. The 
authors reported elevated levels of viral RNA in the patient toilet areas 
and recommended proper disinfection and ventilation. In addition, Van 
Doremalen et al. showed that viable SARS-CoV-2 could be detected in 
aerosols up to 3 hours after aerosolization, and up to 2-3 days on plastic 
and stainless steel [9].
First studies of the gut microbiome of COVID-19 patients showed 
a significant decrease in diversity and abundance compared to healthy 
control (HC) [10]. This was combined with the increased relative 
abundance of opportunistic pathogens like Streptococcus and Rothia. 
The study showed significant disease-specific shifts in the overall 
microbiota composition between COVID-19 and H1N1 patients and 
HC. Changes in the gut microbiome have been shown to associate with 
various diseases, for example IBS, IBD, type 2 diabetes, cardiovascular 
condition and depression. Further studies are needed to evaluate the 
long term effects on SARS-CoV-2 infections in the gut and possibly a 
restorative treatment regime needs to be developed. 
Taken together these results strongly indicate that SARS-CoV-2 
infections in the gut have short- and long-term effects. The short-
term effects are gastrointestinal symptoms and in about 50% of the 
patients viral shedding in stool occurs. Toilet flushing can create 
infectious bioaerosols that are a potential risk factor for oral/nasal-
faecal transmission of SARS-CoV-2. Cleaning procedures of toilets in 
hospitals, care facilities, schools, nurseries, work places, restaurants, 
trains, busses, airplanes and public spaces will need to be looked at 
and perhaps improved.
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